Romanian cold and flu drug market worth €75m in 2009

2010-02-09

Sales of cold and flu medicines in Romania are thought to have reached approximately €75m in 2009, according to Cegedim. During the first eleven months of 2009 such sales were worth RON 289.7m (€69m), which is 6.4% more in terms of value and 12.8% less in terms of units in comparison with the corresponding period of 2008.
The main reason for the healthy sales in this drug category at the end of 2009 was the threat of swine flu, which encouraged Romanians to buy medicines at the first sign of a cold or even for prevention. In November alone sales of cold and flu drugs increased by 23.5% year on year to RON 36.3m (€8.6m).
The best selling drugs in this category in Romania during the first 11 months of 2009 were: Nurofen (Reckitt Benckiser), Paracetamol Sinus (Europharm), Coldrex (GlaxoSmithKline), Erdomed (Medicom) and Fervex (Bristol-Myers Squibb).